Veracyte Financials - Benzinga

Veracyte Inc

VCYTNASDAQ

Trade with Public

Trade with Public

$44.29

0.250.57%

At close: Aug 25, 5:00 PM EST

$44.29

0.250.57%

Pre-Market: 8:29 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Veracyte Financials

Veracyte (VCYT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Veracyte Raises FY2026 Sales Guidance from $582.000M-$592.000M to $590.000M-$596.000M vs $586.445M Est

Veracyte (NASDAQ:VCYT) raises FY2026 sales outlook from $582.000 million-$592.000 million to $590.000 million-$596.000 million vs $586.445 million estimate.

Benzinga Newsdesk

PRO
Veracyte Q2 Adj. EPS $0.54 Beats $0.24 Estimate, Sales $150.321M Beat $144.554M Estimate

Benzinga Newsdesk

PRO
Veracyte Raises FY2026 Sales Guidance from $570.000M-$582.000M to $582.000M-$592.000M vs $576.521M Est

Veracyte (NASDAQ:VCYT) raises FY2026 sales outlook from $570.000 million-$582.000 million to $582.000 million-$592.000 million vs $576.521 million estimate.

Benzinga Newsdesk

PRO
Veracyte Q1 Adj. EPS $0.52 Beats $0.15 Estimate, Sales $139.071M Beat $130.041M Estimate

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.15 by 246.67 percent. This is a 67.74 percent increase over earnings of $0.31 per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Earnings Breakdown: Veracyte Q4

Benzinga Insights